Daniel Lavanchy

TL;DR: More efficacious treatments, mass immunization programs, and safe injection techniques are essential for eliminating HBV infection and reducing global HBV‐related morbidity and mortality.

TL;DR: The global estimate of viraemic HCV infections is lower than previous estimates, largely due to more recent prevalence estimates in Africa, and increased mortality due to liver-related causes and an ageing population may have contributed to a reduction in infections.

TL;DR: The reduction of global mortality and morbidity related to chronic hepatitis C should be a concern to public health authorities, and primary, secondary and tertiary prevention activities should be implemented and monitored in each country, with precise targets set to be reached.

TL;DR: The present assessment finds a global prevalence of 2.35%, affecting 160 million chronically infected individuals, and there is an urgent need for more accurate Information on the costs and burden of HCV to society.

TL;DR: The data suggest that PAT had a major role in the spread of HCV throughout Egypt, and this intensive transmission established a large reservoir of chronic HCV infection, responsible for the high prevalence ofHCV infection and current high rates of transmission.